A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

NCT02009878 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Interventions

DRUG: tolvaptan

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.